Carcinoid tumors

American Family Physician

Volumn 74, Issue 3, 2006, Pages 429-434

  Robertson, Russell G ^a,c   Geiger, William J ^b   Davis, Nancy B ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BRONCHODILATING AGENT; DIURETIC AGENT; LONG ACTING DRUG; OCTREOTIDE; SEROTONIN 3 ANTAGONIST;

APPENDIX TUMOR; ARTIFICIAL EMBOLISM; BRONCHUS TUMOR; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOID; CARCINOID SYNDROME; CLINICAL FEATURE; COLON TUMOR; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FLUSHING; HEART DISEASE; HUMAN; INTESTINE TUMOR; LARGE INTESTINE TUMOR; LUNG TUMOR; METASTASIS; NEUROENDOCRINE TUMOR; PROGNOSIS; RADIODIAGNOSIS; RECTUM TUMOR; REVIEW; STOMACH TUMOR; TRACHEA TUMOR; TUMOR DIAGNOSIS; TUMOR GROWTH; TUMOR LOCALIZATION; URINALYSIS; WHEEZING;

CARCINOID TUMOR; DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; MALIGNANT CARCINOID SYNDROME; PROGNOSIS; RESPIRATORY TRACT NEOPLASMS;

EID: 33747841920     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumors (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncol 2004;43:617-25.
2. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-59.
3. Godwin JD II. Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975;36:560- 9.
4. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-29.
5. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999;340:858-68.
6. Goede AC, Caplin ME, Winslet MC. Carcinoid tumour of the appendix. Br J Surg 2003;90:1317-22.
7. Mayoral W, Salcedo J, Al-Kawas F. Ampullary carcinoid tumor presenting as acute pancreatitis in a patient with von Recklinghausen's disease: case report and review of the literature. Endoscopy 2003;35:854-7.
8. Horton KM, Kamel I, Hofmann L, Fishman EK. Carcinoid tumors of the small bowel: a multitechnique imaging approach. AJR Am J Roentgenol 2004;182:559-67.
9. de Vries H, Verschueren RC, Willemse PH, Kema IP, de Vries EG. Diagnostic, surgical and medical aspect of the midgut carcinoids. Cancer Treat Rev 2002;28:11-25.
10. Metcalfe DD. Differential diagnosis of the patient with unexplained flushing/anaphylaxis. Allergy Asthma Proc 2000;21:21-4.
11. Graham GW, Unger BP, Coursin DB. Perioperative management of selected endocrine disorders. Int Anesthesiol Clin 2000;38:31-67.
12. Hage R, de la Riviere AB, Seldenrijk CA, van den Bosch JM. Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol 2003;10:697-704.
13. Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, et al., for the UKNETwork for Neuroendocrine Tumours. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005;54 (suppl 4):iv1-16.
14. Pearse AG. The APUD concept and hormone production. Clin Endocrinol Metab 1980;9:211-22.
15. Pasieka JL, McKinnon JG, Kinnear S, Yelle CA, Numerow L, Paterson A, et al. Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary. Can J Surg 2001:44;25-32.
16. Roberts LJ, Anthony LB, Oates JA. Disorders of vasodilator hormones; carcinoid syndrome and mastocytosis. In: Williams RH, Wilson JD, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia, Pa.: Saunders, 1998:1711-20.
17. Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, De Herder WW, et al. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab 1997;82:2622-8.
18. Picus D, Glazer HS, Levitt RG, Husband JE. Computed tomography of abdominal carcinoid tumors. AJR Am J Roentgenol 1984;143:581-4.
19. Sundin A, Eriksson B, Bergstrom M, Langstrom B, Oberg K, Orlefors H. PET in the diagnosis of neuroendocrine tumors. Ann N Y Acad Sci 2004;1014:246-57.
20. Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL, et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:895-902.
21. Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 2000;75:310-6.
22. Gerstle JT, Kaufman GL Jr, Koltun WA. The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies. J Am Coll Surg 1995;180:427-32.
23. Jensen RT, Doherty GM. Carcinoid tumors and the carcinoid syndrome. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 7th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins, 2005:1559-74.
24. Oberg K. Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment. Curr Opin Oncol 2002;14:38-45.
25. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumors. Ann Oncol 2001;12(suppl 2):S111-4.
26. Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, et al; for the Nordic NE Tumour Group. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types. Acta Oncol 2004;43:626-36.
27. National Comprehensive Cancer Network. Carcinoid tumors. In: NCCN practice guidelines in oncology - v.2.2005. Neuroendocrine tumors. Accessed March 2, 2006, at: http://www.nccn.org/professionals/physician_gls/PDF/ neuroendocrine.pdf.